nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—migraine—epilepsy syndrome	0.484	1	CtDrD
Timolol—CYP2C19—epilepsy syndrome	0.079	0.44	CbGaD
Timolol—CYP2D6—epilepsy syndrome	0.0586	0.327	CbGaD
Timolol—ABCB1—epilepsy syndrome	0.0418	0.233	CbGaD
Timolol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.015	0.0736	CbGbCtD
Timolol—CYP2C19—Trimethadione—epilepsy syndrome	0.0139	0.0685	CbGbCtD
Timolol—CYP2C19—Felbamate—epilepsy syndrome	0.0139	0.0685	CbGbCtD
Timolol—ABCB1—Levetiracetam—epilepsy syndrome	0.0132	0.065	CbGbCtD
Timolol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0131	0.0644	CbGbCtD
Timolol—CYP2C19—Clobazam—epilepsy syndrome	0.0113	0.0558	CbGbCtD
Timolol—CYP2C19—Carbamazepine—epilepsy syndrome	0.00939	0.0462	CbGbCtD
Timolol—ABCB1—Clobazam—epilepsy syndrome	0.00914	0.045	CbGbCtD
Timolol—ABCB1—Lamotrigine—epilepsy syndrome	0.0088	0.0433	CbGbCtD
Timolol—CYP2C19—Primidone—epilepsy syndrome	0.00877	0.0432	CbGbCtD
Timolol—CYP2C19—Phenytoin—epilepsy syndrome	0.00842	0.0415	CbGbCtD
Timolol—CYP2C19—Propofol—epilepsy syndrome	0.00785	0.0387	CbGbCtD
Timolol—ABCB1—Carbamazepine—epilepsy syndrome	0.00758	0.0373	CbGbCtD
Timolol—CYP2C19—Phenobarbital—epilepsy syndrome	0.00751	0.037	CbGbCtD
Timolol—CYP2C19—Diazepam—epilepsy syndrome	0.00712	0.035	CbGbCtD
Timolol—CYP2C19—Zonisamide—epilepsy syndrome	0.00695	0.0342	CbGbCtD
Timolol—ABCB1—Phenytoin—epilepsy syndrome	0.0068	0.0335	CbGbCtD
Timolol—ABCB1—Phenobarbital—epilepsy syndrome	0.00606	0.0298	CbGbCtD
Timolol—ABCB1—Midazolam—epilepsy syndrome	0.00597	0.0294	CbGbCtD
Timolol—CYP2D6—Propofol—epilepsy syndrome	0.00597	0.0294	CbGbCtD
Timolol—ABCB1—Diazepam—epilepsy syndrome	0.00574	0.0283	CbGbCtD
Timolol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00561	0.0276	CbGbCtD
Timolol—CYP2C19—Topiramate—epilepsy syndrome	0.00506	0.0249	CbGbCtD
Timolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.44e-05	0.000248	CcSEcCtD
Timolol—Cough—Pregabalin—epilepsy syndrome	2.44e-05	0.000248	CcSEcCtD
Timolol—Pruritus—Phenytoin—epilepsy syndrome	2.44e-05	0.000247	CcSEcCtD
Timolol—Connective tissue disorder—Topiramate—epilepsy syndrome	2.44e-05	0.000247	CcSEcCtD
Timolol—Nausea—Levetiracetam—epilepsy syndrome	2.44e-05	0.000247	CcSEcCtD
Timolol—Rash—Vigabatrin—epilepsy syndrome	2.44e-05	0.000247	CcSEcCtD
Timolol—Dizziness—Felbamate—epilepsy syndrome	2.43e-05	0.000246	CcSEcCtD
Timolol—Dermatitis—Vigabatrin—epilepsy syndrome	2.43e-05	0.000246	CcSEcCtD
Timolol—Pruritus—Oxcarbazepine—epilepsy syndrome	2.43e-05	0.000246	CcSEcCtD
Timolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.43e-05	0.000246	CcSEcCtD
Timolol—Vision blurred—Gabapentin—epilepsy syndrome	2.42e-05	0.000245	CcSEcCtD
Timolol—Headache—Vigabatrin—epilepsy syndrome	2.42e-05	0.000245	CcSEcCtD
Timolol—Hypertension—Pregabalin—epilepsy syndrome	2.42e-05	0.000245	CcSEcCtD
Timolol—Vomiting—Diazepam—epilepsy syndrome	2.42e-05	0.000245	CcSEcCtD
Timolol—Anorexia—Valproic Acid—epilepsy syndrome	2.41e-05	0.000244	CcSEcCtD
Timolol—Rash—Diazepam—epilepsy syndrome	2.4e-05	0.000243	CcSEcCtD
Timolol—Dermatitis—Diazepam—epilepsy syndrome	2.4e-05	0.000243	CcSEcCtD
Timolol—Visual impairment—Topiramate—epilepsy syndrome	2.39e-05	0.000242	CcSEcCtD
Timolol—Myalgia—Pregabalin—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Chest pain—Pregabalin—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Arthralgia—Pregabalin—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Dizziness—Zonisamide—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Headache—Diazepam—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Anxiety—Pregabalin—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Diarrhoea—Clonazepam—epilepsy syndrome	2.38e-05	0.000241	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.37e-05	0.00024	CcSEcCtD
Timolol—Hypotension—Valproic Acid—epilepsy syndrome	2.36e-05	0.000239	CcSEcCtD
Timolol—Asthenia—Carbamazepine—epilepsy syndrome	2.36e-05	0.000239	CcSEcCtD
Timolol—Diarrhoea—Phenytoin—epilepsy syndrome	2.36e-05	0.000239	CcSEcCtD
Timolol—Discomfort—Pregabalin—epilepsy syndrome	2.36e-05	0.000239	CcSEcCtD
Timolol—Nausea—Fosphenytoin—epilepsy syndrome	2.35e-05	0.000238	CcSEcCtD
Timolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000238	CcSEcCtD
Timolol—Angioedema—Gabapentin—epilepsy syndrome	2.35e-05	0.000238	CcSEcCtD
Timolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.34e-05	0.000237	CcSEcCtD
Timolol—Vomiting—Felbamate—epilepsy syndrome	2.34e-05	0.000237	CcSEcCtD
Timolol—Dry mouth—Pregabalin—epilepsy syndrome	2.33e-05	0.000236	CcSEcCtD
Timolol—Pruritus—Carbamazepine—epilepsy syndrome	2.33e-05	0.000236	CcSEcCtD
Timolol—Rash—Felbamate—epilepsy syndrome	2.32e-05	0.000235	CcSEcCtD
Timolol—Eye disorder—Topiramate—epilepsy syndrome	2.32e-05	0.000235	CcSEcCtD
Timolol—Dermatitis—Felbamate—epilepsy syndrome	2.32e-05	0.000235	CcSEcCtD
Timolol—Tinnitus—Topiramate—epilepsy syndrome	2.31e-05	0.000234	CcSEcCtD
Timolol—Vertigo—Gabapentin—epilepsy syndrome	2.31e-05	0.000234	CcSEcCtD
Timolol—Headache—Felbamate—epilepsy syndrome	2.31e-05	0.000234	CcSEcCtD
Timolol—Confusional state—Pregabalin—epilepsy syndrome	2.31e-05	0.000233	CcSEcCtD
Timolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.3e-05	0.000233	CcSEcCtD
Timolol—Cardiac disorder—Topiramate—epilepsy syndrome	2.3e-05	0.000233	CcSEcCtD
Timolol—Syncope—Gabapentin—epilepsy syndrome	2.3e-05	0.000233	CcSEcCtD
Timolol—Dizziness—Clonazepam—epilepsy syndrome	2.3e-05	0.000233	CcSEcCtD
Timolol—Nausea—Vigabatrin—epilepsy syndrome	2.29e-05	0.000232	CcSEcCtD
Timolol—Vomiting—Zonisamide—epilepsy syndrome	2.29e-05	0.000232	CcSEcCtD
Timolol—Insomnia—Valproic Acid—epilepsy syndrome	2.29e-05	0.000232	CcSEcCtD
Timolol—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.29e-05	0.000231	CcSEcCtD
Timolol—Oedema—Pregabalin—epilepsy syndrome	2.29e-05	0.000231	CcSEcCtD
Timolol—Asthenia—Lamotrigine—epilepsy syndrome	2.28e-05	0.000231	CcSEcCtD
Timolol—Dizziness—Phenytoin—epilepsy syndrome	2.28e-05	0.000231	CcSEcCtD
Timolol—Rash—Zonisamide—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Infection—Pregabalin—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Paraesthesia—Valproic Acid—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Palpitations—Gabapentin—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Dermatitis—Zonisamide—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Dizziness—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.00023	CcSEcCtD
Timolol—Nausea—Diazepam—epilepsy syndrome	2.26e-05	0.000229	CcSEcCtD
Timolol—Loss of consciousness—Gabapentin—epilepsy syndrome	2.26e-05	0.000229	CcSEcCtD
Timolol—Headache—Zonisamide—epilepsy syndrome	2.26e-05	0.000229	CcSEcCtD
Timolol—Dyspnoea—Valproic Acid—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Diarrhoea—Carbamazepine—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Angiopathy—Topiramate—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Pruritus—Lamotrigine—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Shock—Pregabalin—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Somnolence—Valproic Acid—epilepsy syndrome	2.25e-05	0.000228	CcSEcCtD
Timolol—Immune system disorder—Topiramate—epilepsy syndrome	2.24e-05	0.000227	CcSEcCtD
Timolol—Nervous system disorder—Pregabalin—epilepsy syndrome	2.24e-05	0.000227	CcSEcCtD
Timolol—Cough—Gabapentin—epilepsy syndrome	2.24e-05	0.000227	CcSEcCtD
Timolol—Mediastinal disorder—Topiramate—epilepsy syndrome	2.24e-05	0.000227	CcSEcCtD
Timolol—Dyspepsia—Valproic Acid—epilepsy syndrome	2.23e-05	0.000225	CcSEcCtD
Timolol—Skin disorder—Pregabalin—epilepsy syndrome	2.22e-05	0.000225	CcSEcCtD
Timolol—Hypertension—Gabapentin—epilepsy syndrome	2.22e-05	0.000225	CcSEcCtD
Timolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.21e-05	0.000224	CcSEcCtD
Timolol—Vomiting—Clonazepam—epilepsy syndrome	2.21e-05	0.000224	CcSEcCtD
Timolol—Decreased appetite—Valproic Acid—epilepsy syndrome	2.2e-05	0.000223	CcSEcCtD
Timolol—Alopecia—Topiramate—epilepsy syndrome	2.19e-05	0.000222	CcSEcCtD
Timolol—Vomiting—Phenytoin—epilepsy syndrome	2.19e-05	0.000222	CcSEcCtD
Timolol—Rash—Clonazepam—epilepsy syndrome	2.19e-05	0.000222	CcSEcCtD
Timolol—Dermatitis—Clonazepam—epilepsy syndrome	2.19e-05	0.000222	CcSEcCtD
Timolol—Chest pain—Gabapentin—epilepsy syndrome	2.19e-05	0.000221	CcSEcCtD
Timolol—Arthralgia—Gabapentin—epilepsy syndrome	2.19e-05	0.000221	CcSEcCtD
Timolol—Myalgia—Gabapentin—epilepsy syndrome	2.19e-05	0.000221	CcSEcCtD
Timolol—Nausea—Felbamate—epilepsy syndrome	2.19e-05	0.000221	CcSEcCtD
Timolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.18e-05	0.000221	CcSEcCtD
Timolol—Vomiting—Oxcarbazepine—epilepsy syndrome	2.18e-05	0.000221	CcSEcCtD
Timolol—Fatigue—Valproic Acid—epilepsy syndrome	2.18e-05	0.000221	CcSEcCtD
Timolol—Anxiety—Gabapentin—epilepsy syndrome	2.18e-05	0.000221	CcSEcCtD
Timolol—Anorexia—Pregabalin—epilepsy syndrome	2.18e-05	0.000221	CcSEcCtD
Timolol—Dizziness—Carbamazepine—epilepsy syndrome	2.18e-05	0.00022	CcSEcCtD
Timolol—Diarrhoea—Lamotrigine—epilepsy syndrome	2.18e-05	0.00022	CcSEcCtD
Timolol—Headache—Clonazepam—epilepsy syndrome	2.18e-05	0.00022	CcSEcCtD
Timolol—Rash—Phenytoin—epilepsy syndrome	2.18e-05	0.00022	CcSEcCtD
Timolol—Mental disorder—Topiramate—epilepsy syndrome	2.17e-05	0.00022	CcSEcCtD
Timolol—Dermatitis—Phenytoin—epilepsy syndrome	2.17e-05	0.00022	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.17e-05	0.00022	CcSEcCtD
Timolol—Rash—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Pain—Valproic Acid—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Headache—Phenytoin—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Erythema—Topiramate—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Malnutrition—Topiramate—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Discomfort—Gabapentin—epilepsy syndrome	2.16e-05	0.000219	CcSEcCtD
Timolol—Headache—Oxcarbazepine—epilepsy syndrome	2.15e-05	0.000218	CcSEcCtD
Timolol—Nausea—Zonisamide—epilepsy syndrome	2.14e-05	0.000217	CcSEcCtD
Timolol—Dry mouth—Gabapentin—epilepsy syndrome	2.14e-05	0.000217	CcSEcCtD
Timolol—Hypotension—Pregabalin—epilepsy syndrome	2.14e-05	0.000216	CcSEcCtD
Timolol—Tension—Topiramate—epilepsy syndrome	2.12e-05	0.000215	CcSEcCtD
Timolol—Dysgeusia—Topiramate—epilepsy syndrome	2.12e-05	0.000214	CcSEcCtD
Timolol—Confusional state—Gabapentin—epilepsy syndrome	2.11e-05	0.000214	CcSEcCtD
Timolol—Dizziness—Lamotrigine—epilepsy syndrome	2.1e-05	0.000213	CcSEcCtD
Timolol—Nervousness—Topiramate—epilepsy syndrome	2.1e-05	0.000213	CcSEcCtD
Timolol—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.1e-05	0.000212	CcSEcCtD
Timolol—Oedema—Gabapentin—epilepsy syndrome	2.1e-05	0.000212	CcSEcCtD
Timolol—Vomiting—Carbamazepine—epilepsy syndrome	2.09e-05	0.000212	CcSEcCtD
Timolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.08e-05	0.000211	CcSEcCtD
Timolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.08e-05	0.000211	CcSEcCtD
Timolol—Infection—Gabapentin—epilepsy syndrome	2.08e-05	0.000211	CcSEcCtD
Timolol—Rash—Carbamazepine—epilepsy syndrome	2.08e-05	0.00021	CcSEcCtD
Timolol—Dermatitis—Carbamazepine—epilepsy syndrome	2.07e-05	0.00021	CcSEcCtD
Timolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.07e-05	0.000209	CcSEcCtD
Timolol—Insomnia—Pregabalin—epilepsy syndrome	2.07e-05	0.000209	CcSEcCtD
Timolol—Nausea—Clonazepam—epilepsy syndrome	2.06e-05	0.000209	CcSEcCtD
Timolol—Headache—Carbamazepine—epilepsy syndrome	2.06e-05	0.000209	CcSEcCtD
Timolol—Shock—Gabapentin—epilepsy syndrome	2.06e-05	0.000209	CcSEcCtD
Timolol—Nervous system disorder—Gabapentin—epilepsy syndrome	2.06e-05	0.000208	CcSEcCtD
Timolol—Paraesthesia—Pregabalin—epilepsy syndrome	2.05e-05	0.000208	CcSEcCtD
Timolol—Nausea—Phenytoin—epilepsy syndrome	2.05e-05	0.000207	CcSEcCtD
Timolol—Dyspnoea—Pregabalin—epilepsy syndrome	2.04e-05	0.000206	CcSEcCtD
Timolol—Nausea—Oxcarbazepine—epilepsy syndrome	2.04e-05	0.000206	CcSEcCtD
Timolol—Vision blurred—Topiramate—epilepsy syndrome	2.04e-05	0.000206	CcSEcCtD
Timolol—Skin disorder—Gabapentin—epilepsy syndrome	2.04e-05	0.000206	CcSEcCtD
Timolol—Somnolence—Pregabalin—epilepsy syndrome	2.03e-05	0.000206	CcSEcCtD
Timolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.03e-05	0.000205	CcSEcCtD
Timolol—Vomiting—Lamotrigine—epilepsy syndrome	2.02e-05	0.000205	CcSEcCtD
Timolol—Urticaria—Valproic Acid—epilepsy syndrome	2.01e-05	0.000203	CcSEcCtD
Timolol—Rash—Lamotrigine—epilepsy syndrome	2.01e-05	0.000203	CcSEcCtD
Timolol—Dermatitis—Lamotrigine—epilepsy syndrome	2e-05	0.000203	CcSEcCtD
Timolol—Abdominal pain—Valproic Acid—epilepsy syndrome	2e-05	0.000202	CcSEcCtD
Timolol—Body temperature increased—Valproic Acid—epilepsy syndrome	2e-05	0.000202	CcSEcCtD
Timolol—Anorexia—Gabapentin—epilepsy syndrome	2e-05	0.000202	CcSEcCtD
Timolol—Headache—Lamotrigine—epilepsy syndrome	1.99e-05	0.000202	CcSEcCtD
Timolol—Decreased appetite—Pregabalin—epilepsy syndrome	1.99e-05	0.000201	CcSEcCtD
Timolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.97e-05	0.0002	CcSEcCtD
Timolol—Fatigue—Pregabalin—epilepsy syndrome	1.97e-05	0.0002	CcSEcCtD
Timolol—Hypotension—Gabapentin—epilepsy syndrome	1.96e-05	0.000198	CcSEcCtD
Timolol—Nausea—Carbamazepine—epilepsy syndrome	1.96e-05	0.000198	CcSEcCtD
Timolol—Pain—Pregabalin—epilepsy syndrome	1.96e-05	0.000198	CcSEcCtD
Timolol—Vertigo—Topiramate—epilepsy syndrome	1.94e-05	0.000197	CcSEcCtD
Timolol—Syncope—Topiramate—epilepsy syndrome	1.94e-05	0.000196	CcSEcCtD
Timolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.91e-05	0.000193	CcSEcCtD
Timolol—Palpitations—Topiramate—epilepsy syndrome	1.91e-05	0.000193	CcSEcCtD
Timolol—Loss of consciousness—Topiramate—epilepsy syndrome	1.9e-05	0.000192	CcSEcCtD
Timolol—Insomnia—Gabapentin—epilepsy syndrome	1.9e-05	0.000192	CcSEcCtD
Timolol—Nausea—Lamotrigine—epilepsy syndrome	1.89e-05	0.000191	CcSEcCtD
Timolol—Cough—Topiramate—epilepsy syndrome	1.89e-05	0.000191	CcSEcCtD
Timolol—Feeling abnormal—Pregabalin—epilepsy syndrome	1.88e-05	0.000191	CcSEcCtD
Timolol—Paraesthesia—Gabapentin—epilepsy syndrome	1.88e-05	0.000191	CcSEcCtD
Timolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.87e-05	0.000189	CcSEcCtD
Timolol—Dyspnoea—Gabapentin—epilepsy syndrome	1.87e-05	0.000189	CcSEcCtD
Timolol—Hypertension—Topiramate—epilepsy syndrome	1.87e-05	0.000189	CcSEcCtD
Timolol—Somnolence—Gabapentin—epilepsy syndrome	1.86e-05	0.000189	CcSEcCtD
Timolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.86e-05	0.000189	CcSEcCtD
Timolol—Dyspepsia—Gabapentin—epilepsy syndrome	1.85e-05	0.000187	CcSEcCtD
Timolol—Arthralgia—Topiramate—epilepsy syndrome	1.84e-05	0.000186	CcSEcCtD
Timolol—Myalgia—Topiramate—epilepsy syndrome	1.84e-05	0.000186	CcSEcCtD
Timolol—Chest pain—Topiramate—epilepsy syndrome	1.84e-05	0.000186	CcSEcCtD
Timolol—Anxiety—Topiramate—epilepsy syndrome	1.83e-05	0.000186	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.83e-05	0.000185	CcSEcCtD
Timolol—Decreased appetite—Gabapentin—epilepsy syndrome	1.82e-05	0.000185	CcSEcCtD
Timolol—Discomfort—Topiramate—epilepsy syndrome	1.82e-05	0.000184	CcSEcCtD
Timolol—Urticaria—Pregabalin—epilepsy syndrome	1.82e-05	0.000184	CcSEcCtD
Timolol—Asthenia—Valproic Acid—epilepsy syndrome	1.81e-05	0.000184	CcSEcCtD
Timolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.81e-05	0.000183	CcSEcCtD
Timolol—Fatigue—Gabapentin—epilepsy syndrome	1.81e-05	0.000183	CcSEcCtD
Timolol—Abdominal pain—Pregabalin—epilepsy syndrome	1.81e-05	0.000183	CcSEcCtD
Timolol—Body temperature increased—Pregabalin—epilepsy syndrome	1.81e-05	0.000183	CcSEcCtD
Timolol—Dry mouth—Topiramate—epilepsy syndrome	1.8e-05	0.000182	CcSEcCtD
Timolol—Pain—Gabapentin—epilepsy syndrome	1.79e-05	0.000182	CcSEcCtD
Timolol—Pruritus—Valproic Acid—epilepsy syndrome	1.79e-05	0.000181	CcSEcCtD
Timolol—Confusional state—Topiramate—epilepsy syndrome	1.78e-05	0.00018	CcSEcCtD
Timolol—Oedema—Topiramate—epilepsy syndrome	1.76e-05	0.000179	CcSEcCtD
Timolol—Infection—Topiramate—epilepsy syndrome	1.75e-05	0.000177	CcSEcCtD
Timolol—Shock—Topiramate—epilepsy syndrome	1.74e-05	0.000176	CcSEcCtD
Timolol—Diarrhoea—Valproic Acid—epilepsy syndrome	1.73e-05	0.000175	CcSEcCtD
Timolol—Nervous system disorder—Topiramate—epilepsy syndrome	1.73e-05	0.000175	CcSEcCtD
Timolol—Feeling abnormal—Gabapentin—epilepsy syndrome	1.73e-05	0.000175	CcSEcCtD
Timolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.71e-05	0.000174	CcSEcCtD
Timolol—Skin disorder—Topiramate—epilepsy syndrome	1.71e-05	0.000173	CcSEcCtD
Timolol—Hyperhidrosis—Topiramate—epilepsy syndrome	1.71e-05	0.000173	CcSEcCtD
Timolol—Hypersensitivity—Pregabalin—epilepsy syndrome	1.68e-05	0.000171	CcSEcCtD
Timolol—Anorexia—Topiramate—epilepsy syndrome	1.68e-05	0.00017	CcSEcCtD
Timolol—Dizziness—Valproic Acid—epilepsy syndrome	1.67e-05	0.000169	CcSEcCtD
Timolol—Urticaria—Gabapentin—epilepsy syndrome	1.67e-05	0.000169	CcSEcCtD
Timolol—Abdominal pain—Gabapentin—epilepsy syndrome	1.66e-05	0.000168	CcSEcCtD
Timolol—Body temperature increased—Gabapentin—epilepsy syndrome	1.66e-05	0.000168	CcSEcCtD
Timolol—Hypotension—Topiramate—epilepsy syndrome	1.65e-05	0.000167	CcSEcCtD
Timolol—Asthenia—Pregabalin—epilepsy syndrome	1.64e-05	0.000166	CcSEcCtD
Timolol—Pruritus—Pregabalin—epilepsy syndrome	1.62e-05	0.000164	CcSEcCtD
Timolol—Vomiting—Valproic Acid—epilepsy syndrome	1.61e-05	0.000163	CcSEcCtD
Timolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.61e-05	0.000163	CcSEcCtD
Timolol—Insomnia—Topiramate—epilepsy syndrome	1.6e-05	0.000162	CcSEcCtD
Timolol—Rash—Valproic Acid—epilepsy syndrome	1.59e-05	0.000161	CcSEcCtD
Timolol—Dermatitis—Valproic Acid—epilepsy syndrome	1.59e-05	0.000161	CcSEcCtD
Timolol—Headache—Valproic Acid—epilepsy syndrome	1.58e-05	0.00016	CcSEcCtD
Timolol—Paraesthesia—Topiramate—epilepsy syndrome	1.58e-05	0.00016	CcSEcCtD
Timolol—Dyspnoea—Topiramate—epilepsy syndrome	1.57e-05	0.000159	CcSEcCtD
Timolol—Somnolence—Topiramate—epilepsy syndrome	1.57e-05	0.000159	CcSEcCtD
Timolol—Diarrhoea—Pregabalin—epilepsy syndrome	1.56e-05	0.000158	CcSEcCtD
Timolol—Dyspepsia—Topiramate—epilepsy syndrome	1.55e-05	0.000157	CcSEcCtD
Timolol—Hypersensitivity—Gabapentin—epilepsy syndrome	1.54e-05	0.000156	CcSEcCtD
Timolol—Decreased appetite—Topiramate—epilepsy syndrome	1.53e-05	0.000155	CcSEcCtD
Timolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.52e-05	0.000154	CcSEcCtD
Timolol—Fatigue—Topiramate—epilepsy syndrome	1.52e-05	0.000154	CcSEcCtD
Timolol—Dizziness—Pregabalin—epilepsy syndrome	1.51e-05	0.000153	CcSEcCtD
Timolol—Pain—Topiramate—epilepsy syndrome	1.51e-05	0.000153	CcSEcCtD
Timolol—Asthenia—Gabapentin—epilepsy syndrome	1.5e-05	0.000152	CcSEcCtD
Timolol—Nausea—Valproic Acid—epilepsy syndrome	1.5e-05	0.000152	CcSEcCtD
Timolol—Pruritus—Gabapentin—epilepsy syndrome	1.48e-05	0.00015	CcSEcCtD
Timolol—Vomiting—Pregabalin—epilepsy syndrome	1.45e-05	0.000147	CcSEcCtD
Timolol—Feeling abnormal—Topiramate—epilepsy syndrome	1.45e-05	0.000147	CcSEcCtD
Timolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.44e-05	0.000146	CcSEcCtD
Timolol—Rash—Pregabalin—epilepsy syndrome	1.44e-05	0.000146	CcSEcCtD
Timolol—Dermatitis—Pregabalin—epilepsy syndrome	1.44e-05	0.000146	CcSEcCtD
Timolol—Diarrhoea—Gabapentin—epilepsy syndrome	1.43e-05	0.000145	CcSEcCtD
Timolol—Headache—Pregabalin—epilepsy syndrome	1.43e-05	0.000145	CcSEcCtD
Timolol—Urticaria—Topiramate—epilepsy syndrome	1.4e-05	0.000142	CcSEcCtD
Timolol—Abdominal pain—Topiramate—epilepsy syndrome	1.39e-05	0.000141	CcSEcCtD
Timolol—Body temperature increased—Topiramate—epilepsy syndrome	1.39e-05	0.000141	CcSEcCtD
Timolol—Dizziness—Gabapentin—epilepsy syndrome	1.39e-05	0.00014	CcSEcCtD
Timolol—Nausea—Pregabalin—epilepsy syndrome	1.36e-05	0.000137	CcSEcCtD
Timolol—Vomiting—Gabapentin—epilepsy syndrome	1.33e-05	0.000135	CcSEcCtD
Timolol—Rash—Gabapentin—epilepsy syndrome	1.32e-05	0.000134	CcSEcCtD
Timolol—Dermatitis—Gabapentin—epilepsy syndrome	1.32e-05	0.000134	CcSEcCtD
Timolol—Headache—Gabapentin—epilepsy syndrome	1.31e-05	0.000133	CcSEcCtD
Timolol—Hypersensitivity—Topiramate—epilepsy syndrome	1.3e-05	0.000132	CcSEcCtD
Timolol—Asthenia—Topiramate—epilepsy syndrome	1.27e-05	0.000128	CcSEcCtD
Timolol—Pruritus—Topiramate—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Timolol—Nausea—Gabapentin—epilepsy syndrome	1.25e-05	0.000126	CcSEcCtD
Timolol—Diarrhoea—Topiramate—epilepsy syndrome	1.21e-05	0.000122	CcSEcCtD
Timolol—Dizziness—Topiramate—epilepsy syndrome	1.17e-05	0.000118	CcSEcCtD
Timolol—Vomiting—Topiramate—epilepsy syndrome	1.12e-05	0.000114	CcSEcCtD
Timolol—Rash—Topiramate—epilepsy syndrome	1.11e-05	0.000113	CcSEcCtD
Timolol—Dermatitis—Topiramate—epilepsy syndrome	1.11e-05	0.000112	CcSEcCtD
Timolol—Headache—Topiramate—epilepsy syndrome	1.1e-05	0.000112	CcSEcCtD
Timolol—Nausea—Topiramate—epilepsy syndrome	1.05e-05	0.000106	CcSEcCtD
Timolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	5.08e-06	0.000148	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	5.08e-06	0.000148	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MEF2C—epilepsy syndrome	5.07e-06	0.000148	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADSL—epilepsy syndrome	5.05e-06	0.000147	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	5.03e-06	0.000147	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	5e-06	0.000146	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5e-06	0.000146	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	4.98e-06	0.000145	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	4.98e-06	0.000145	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GLUL—epilepsy syndrome	4.95e-06	0.000145	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.93e-06	0.000144	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.9e-06	0.000143	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	4.87e-06	0.000142	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	4.87e-06	0.000142	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	4.86e-06	0.000142	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NGF—epilepsy syndrome	4.85e-06	0.000142	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	4.85e-06	0.000141	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	4.85e-06	0.000141	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	4.85e-06	0.000141	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.84e-06	0.000141	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	4.8e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	4.8e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	4.8e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	4.8e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	4.8e-06	0.00014	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.75e-06	0.000139	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	4.74e-06	0.000138	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	4.74e-06	0.000138	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	4.74e-06	0.000138	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.72e-06	0.000138	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCR5—epilepsy syndrome	4.72e-06	0.000138	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	4.7e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	4.7e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	4.7e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	4.7e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	4.7e-06	0.000137	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.65e-06	0.000136	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	4.64e-06	0.000135	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	4.64e-06	0.000135	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	4.62e-06	0.000135	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.6e-06	0.000134	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.56e-06	0.000133	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	4.55e-06	0.000133	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.54e-06	0.000132	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.48e-06	0.000131	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.47e-06	0.000131	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	4.47e-06	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	4.47e-06	0.00013	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.44e-06	0.00013	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AQP1—epilepsy syndrome	4.42e-06	0.000129	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.41e-06	0.000129	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	4.4e-06	0.000128	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	4.39e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.38e-06	0.000128	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	4.38e-06	0.000128	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.37e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	4.37e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	4.37e-06	0.000128	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	4.35e-06	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	4.35e-06	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	4.35e-06	0.000127	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.31e-06	0.000126	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	4.31e-06	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	4.31e-06	0.000126	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	4.29e-06	0.000125	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.25e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	4.25e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	4.25e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	4.25e-06	0.000124	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.24e-06	0.000124	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	4.23e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	4.21e-06	0.000123	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	4.2e-06	0.000123	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.18e-06	0.000122	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.16e-06	0.000121	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	4.14e-06	0.000121	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	4.09e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.09e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	4.08e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.07e-06	0.000119	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.06e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.05e-06	0.000118	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	4.05e-06	0.000118	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	4.03e-06	0.000118	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	4.01e-06	0.000117	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	4.01e-06	0.000117	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	4e-06	0.000117	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	4e-06	0.000117	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	4e-06	0.000117	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.99e-06	0.000117	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.99e-06	0.000117	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	3.99e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.98e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.96e-06	0.000116	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.94e-06	0.000115	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	3.92e-06	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	3.92e-06	0.000114	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	3.91e-06	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	3.91e-06	0.000114	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.9e-06	0.000114	CbGpPWpGaD
Timolol—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.9e-06	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	3.83e-06	0.000112	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	3.8e-06	0.000111	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	3.73e-06	0.000109	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.72e-06	0.000109	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	3.72e-06	0.000108	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	3.7e-06	0.000108	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	3.69e-06	0.000108	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.67e-06	0.000107	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.67e-06	0.000107	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	3.65e-06	0.000106	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.64e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	3.64e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	3.62e-06	0.000106	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	3.62e-06	0.000106	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	3.61e-06	0.000105	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	3.56e-06	0.000104	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	3.55e-06	0.000103	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	3.44e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	3.41e-06	9.95e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	3.4e-06	9.93e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	3.37e-06	9.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	3.34e-06	9.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	3.33e-06	9.71e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	3.29e-06	9.61e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	3.26e-06	9.52e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.26e-06	9.5e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	3.22e-06	9.4e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.18e-06	9.27e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.15e-06	9.2e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.13e-06	9.14e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	3.11e-06	9.09e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.1e-06	9.04e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.08e-06	8.98e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	3.05e-06	8.89e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	3.03e-06	8.84e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	3.03e-06	8.83e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	3.02e-06	8.81e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	3.01e-06	8.79e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.99e-06	8.74e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	2.97e-06	8.66e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	2.96e-06	8.65e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	2.95e-06	8.61e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	2.95e-06	8.6e-05	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.93e-06	8.56e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.92e-06	8.52e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.91e-06	8.5e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.9e-06	8.46e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	2.88e-06	8.4e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.85e-06	8.33e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.85e-06	8.31e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.85e-06	8.3e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	2.82e-06	8.22e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	2.8e-06	8.17e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.78e-06	8.11e-05	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.76e-06	8.04e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	2.74e-06	8e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	2.74e-06	7.99e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	2.73e-06	7.97e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.71e-06	7.91e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.7e-06	7.87e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	2.68e-06	7.82e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	2.65e-06	7.74e-05	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.65e-06	7.73e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.64e-06	7.72e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.63e-06	7.68e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	2.6e-06	7.6e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	2.6e-06	7.59e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	2.58e-06	7.53e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.57e-06	7.51e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	2.55e-06	7.44e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	2.55e-06	7.43e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.55e-06	7.43e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	2.54e-06	7.42e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TH—epilepsy syndrome	2.54e-06	7.4e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.51e-06	7.33e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	2.5e-06	7.3e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.5e-06	7.29e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	2.5e-06	7.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	2.49e-06	7.27e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.49e-06	7.27e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.48e-06	7.25e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.48e-06	7.24e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TH—epilepsy syndrome	2.48e-06	7.22e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	2.44e-06	7.13e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	2.4e-06	7.01e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	2.39e-06	6.98e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	2.38e-06	6.94e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.37e-06	6.91e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	2.35e-06	6.86e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.34e-06	6.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	2.34e-06	6.83e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TH—epilepsy syndrome	2.33e-06	6.81e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	2.32e-06	6.76e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	2.19e-06	6.39e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	2.14e-06	6.25e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	2.14e-06	6.25e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.12e-06	6.18e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	2.09e-06	6.11e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.09e-06	6.1e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.07e-06	6.03e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAT—epilepsy syndrome	2.04e-06	5.95e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.03e-06	5.93e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.95e-06	5.68e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.94e-06	5.65e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.92e-06	5.61e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	1.89e-06	5.53e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.89e-06	5.51e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.87e-06	5.45e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.84e-06	5.38e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	1.8e-06	5.24e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	1.76e-06	5.14e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	1.76e-06	5.13e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.74e-06	5.07e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	1.72e-06	5.03e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.66e-06	4.83e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.64e-06	4.77e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.62e-06	4.74e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	1.62e-06	4.73e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AGT—epilepsy syndrome	1.62e-06	4.72e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.6e-06	4.67e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.59e-06	4.63e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOE—epilepsy syndrome	1.58e-06	4.62e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	1.57e-06	4.59e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	1.54e-06	4.49e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	1.53e-06	4.47e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.52e-06	4.45e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.5e-06	4.37e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.49e-06	4.36e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.49e-06	4.33e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	1.48e-06	4.31e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.45e-06	4.24e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	1.41e-06	4.12e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.39e-06	4.07e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	1.38e-06	4.03e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	1.37e-06	4.01e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—POMC—epilepsy syndrome	1.36e-06	3.97e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	1.35e-06	3.93e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.28e-06	3.74e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.27e-06	3.71e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—epilepsy syndrome	1.24e-06	3.62e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.17e-06	3.41e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.11e-06	3.25e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	3.17e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	2.98e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	8.77e-07	2.56e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	8.58e-07	2.5e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.59e-07	1.63e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.45e-07	1.59e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.14e-07	1.5e-05	CbGpPWpGaD
